LU73738A1 - - Google Patents

Info

Publication number
LU73738A1
LU73738A1 LU73738A LU73738A LU73738A1 LU 73738 A1 LU73738 A1 LU 73738A1 LU 73738 A LU73738 A LU 73738A LU 73738 A LU73738 A LU 73738A LU 73738 A1 LU73738 A1 LU 73738A1
Authority
LU
Luxembourg
Application number
LU73738A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7436963A external-priority patent/FR2313060A1/fr
Priority claimed from FR7527161A external-priority patent/FR2322601A1/fr
Priority claimed from FR7527162A external-priority patent/FR2322602A1/fr
Priority claimed from FR7527160A external-priority patent/FR2322600A1/fr
Application filed filed Critical
Publication of LU73738A1 publication Critical patent/LU73738A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
LU73738A 1974-11-07 1975-11-06 LU73738A1 (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR7436963A FR2313060A1 (fr) 1974-11-07 1974-11-07 Nouveaux derives de l'isoindoline, leur preparation et les compositions qui les contiennent
FR7527161A FR2322601A1 (fr) 1975-09-04 1975-09-04 Nouveaux derives de l'isoindoline, leur preparation et les compositions qui les contiennent
FR7527162A FR2322602A1 (fr) 1975-09-04 1975-09-04 Nouveaux derives de l'oxathiinno- et du dithiinnopyrrole, leur preparation et les compositions qui les contiennent
FR7527160A FR2322600A1 (fr) 1975-09-04 1975-09-04 Nouveaux derives de la pyrrolo (3,4-b) pyrazine, leur preparation et les compositions qui les contiennent

Publications (1)

Publication Number Publication Date
LU73738A1 true LU73738A1 (sv) 1976-09-06

Family

ID=27446274

Family Applications (1)

Application Number Title Priority Date Filing Date
LU73738A LU73738A1 (sv) 1974-11-07 1975-11-06

Country Status (27)

Country Link
US (1) US4220646A (sv)
JP (2) JPS5422996B2 (sv)
AR (2) AR208414A1 (sv)
AT (2) AT343123B (sv)
AU (1) AU503200B2 (sv)
BE (1) BE835325A (sv)
CA (1) CA1057755A (sv)
CH (1) CH609057A5 (sv)
CS (2) CS231957B2 (sv)
CY (1) CY1045A (sv)
DD (1) DD122684A5 (sv)
DE (1) DE2550111C2 (sv)
DK (1) DK141098B (sv)
FI (1) FI60707C (sv)
GB (1) GB1468497A (sv)
HK (1) HK19380A (sv)
HU (1) HU173108B (sv)
IE (1) IE41928B1 (sv)
IL (1) IL48423A (sv)
LU (1) LU73738A1 (sv)
NL (1) NL177405C (sv)
NO (1) NO143576C (sv)
OA (1) OA05162A (sv)
PL (1) PL101248B1 (sv)
SE (1) SE407063B (sv)
SU (2) SU673173A3 (sv)
YU (2) YU39583B (sv)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2371198A2 (fr) * 1976-11-22 1978-06-16 Rhone Poulenc Ind Nouveaux derives du dithiepinno (1,4)(2,3-c) pyrrole, leur preparation et les compositions qui les contiennent
US4533751A (en) * 1981-10-09 1985-08-06 Scm Corporation Preparation of 1,3-dienamines from myrcene and substituted myrcene
FR2525606A1 (fr) * 1982-04-22 1983-10-28 Rhone Poulenc Sante Nouveaux derives du dithiino (1,4) (2,3-c) pyrrole, leur preparation et les medicaments qui les contiennent
FR2607504B1 (fr) * 1986-12-02 1989-01-27 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2607506B1 (fr) * 1986-12-02 1989-01-06 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2671800B1 (fr) * 1991-01-17 1993-03-12 Rhone Poulenc Rorer Sa Derive de la 5h-pyrrolo[3,4-b]pyrazine optiquement actif, sa preparation et les compositions pharmaceutiques qui le contiennent.
US5786357A (en) 1991-12-02 1998-07-28 Sepracor Inc. Methods and compositions for treating sleep disorders, convulsive seizures and other disorders using optically pure (+) zopiclone
HU214331B (hu) * 1992-06-17 1998-03-02 Gyógyszerkutató Intézet Kft. Eljárás piperazin- és homopiperazinszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
US5565567A (en) * 1993-06-04 1996-10-15 Henkel Corporation. Polymerizable N,N'-substituted piperazine acrylamide compounds
JPH08511022A (ja) * 1993-06-04 1996-11-19 ヘンケル コーポレーション 重合可能な化合物
US5922820A (en) * 1993-06-04 1999-07-13 Henkel Corporation Polymerizable compounds
HUT77770A (hu) * 1994-09-23 1998-08-28 Axys Pharmaceuticals, Inc. Készítmény és eljárás hízósejtek által közvetített gyulladásos állapotok kezelésére
US5663357A (en) 1995-11-22 1997-09-02 Allergan Substituted heteroarylamides having retinoid-like biological activity
US5756742A (en) * 1995-12-22 1998-05-26 Henkel Corporation Polymerizable compounds
US6339086B1 (en) 1999-05-14 2002-01-15 Swpracor, Inc. Methods of making and using N-desmethylzopiclone
JP4196678B2 (ja) * 2001-04-26 2008-12-17 味の素株式会社 複素環化合物
RU2318823C2 (ru) * 2002-03-29 2008-03-10 Индивус Фармасьютикалз, Инк. Способы получения 2-(7-хлор-1,8-нафтиридин-2-ил)-3-(5-метил-2-оксогексил)-1-изоиндолинона
WO2004037212A2 (en) * 2002-10-24 2004-05-06 Sepracor, Inc. Compositions comprising zopiclone derivatives and methods of making and using the same
AR042194A1 (es) * 2002-11-22 2005-06-15 Merck & Co Inc Metodo para preparar inhibidores de fosfodiesterasa - 4
CN1326856C (zh) * 2002-11-22 2007-07-18 麦克公司 制备磷酸二酯酶-4抑制剂的方法
US6909002B2 (en) * 2002-11-22 2005-06-21 Merck & Co., Inc. Method of preparing inhibitors of phosphodiesterase-4
DK1691811T3 (da) 2003-12-11 2014-10-20 Sunovion Pharmaceuticals Inc Kombination af et sedativ og en neurotransmittermodulator og fremgangsmåder til forbedring af søvnkvaliteten og behandling af depression
US20050232983A1 (en) * 2004-04-14 2005-10-20 Indevus Pharmaceuticals, Inc. Transdermal patch
US20090111818A1 (en) * 2005-07-06 2009-04-30 Sepracor Inc. Combinations of Eszopiclone and O-Desmethylvenlafaxine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders
JP2009500425A (ja) 2005-07-06 2009-01-08 セプラコア インコーポレーテッド エスゾピクロン及びトランス4−(3,4−ジクロロフェニル)−1,2,3,4−テトラヒドロ−n−メチル−1−ナフタレンアミン又はトランス4−(3,4−ジクロロフェニル)−1,2,3,4−テトラヒドロ−1−ナフタレンアミンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法
WO2007025177A2 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス,インコーポレイティド Pde阻害による神経新生の調節
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
AU2007292848A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20080305171A1 (en) * 2007-06-07 2008-12-11 Kristin Anne Arnold Pyrrolopyrazine, formulations, methods of manufacture, and methods of use there
CN100569775C (zh) * 2007-12-19 2009-12-16 齐鲁天和惠世制药有限公司 佐匹克隆的晶型转换的方法
EP3632417A1 (en) 2009-01-30 2020-04-08 Sunovion Pharmaceuticals Inc. Coated tablets of 6-(5-chloro-2-pyridyl) -5-[ (4-methyl-1-piperazinyl) carbonyloxy]-7-oxo-6, 7-dihydro-5h-pyrrolo [3,4-b] pyrazine
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
CN110678497B (zh) * 2017-05-25 2022-09-16 信越化学工业株式会社 含有氟聚醚基的聚合物改性有机硅化合物、表面处理剂和物品
CN108129476A (zh) * 2017-11-27 2018-06-08 华中农业大学 一种杂环内酰胺衍生物及其用于作物病原菌杀菌剂的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1312427A (fr) * 1961-04-12 1962-12-21 Science Union Et Compagnie Soc Nouveaux dérivés de la pipérazine et leurs préparations
FR2101081B1 (sv) * 1970-08-19 1974-01-11 Rhone Poulenc Sa
BE790408A (fr) * 1971-10-22 1973-04-20 Rhone Poulenc Sa Nouveaux derives de la pyrrolo (3,4-b) pyridine, leur preparation et les compositions medicinales qui les
OA04285A (fr) * 1972-01-07 1979-12-31 Rhone Poulenc Sa Nouveaux dérivés de la pyrrolo (3,4-b) pyrazine et leur préparation.
BE793851A (fr) * 1972-01-10 1973-07-10 Rhone Poulenc Sa Nouveaux derives de l'isoindoline, leur preparation et les compositions medicinales qui les contiennent
AR207555A1 (es) * 1972-12-04 1976-10-15 Procedimiento para preparar aril-6-piperazinocarboniloxi-5 oxo-7 tetrahidro-2,3,6,7 ditiino(1,4)(2,3-c)pirroles
OA04700A (fr) * 1973-05-15 1980-07-31 Rhone Poulenc Sa Nouveaux dérivés de la naphtyridine et leur procédé de préparation.

Also Published As

Publication number Publication date
FI60707C (fi) 1982-03-10
AU8633175A (en) 1977-05-12
NL177405C (nl) 1985-09-16
CS598377A2 (en) 1984-01-16
AU503200B2 (en) 1979-08-30
CA1057755A (fr) 1979-07-03
DK141098B (da) 1980-01-14
OA05162A (fr) 1981-01-31
CS751075A2 (en) 1984-01-16
AT343123B (de) 1978-05-10
NL7512732A (nl) 1976-05-11
ATA401977A (de) 1977-10-15
YU40087B (en) 1985-06-30
DK499275A (sv) 1976-05-08
CS231957B2 (en) 1985-01-16
NO143576B (no) 1980-12-01
CH609057A5 (sv) 1979-02-15
AT343666B (de) 1978-06-12
DK141098C (sv) 1980-07-07
JPS5422996B2 (sv) 1979-08-10
CY1045A (en) 1980-08-01
JPS5170776A (sv) 1976-06-18
DE2550111A1 (de) 1976-05-13
AR208414A1 (es) 1976-12-27
YU192182A (en) 1983-01-21
PL101248B1 (pl) 1978-12-30
HK19380A (en) 1980-04-18
IL48423A (en) 1979-03-12
ATA848675A (de) 1977-09-15
SE7512477L (sv) 1976-05-08
IL48423A0 (en) 1976-01-30
GB1468497A (en) 1977-03-30
JPS558508B2 (sv) 1980-03-04
NO143576C (no) 1981-03-11
US4220646A (en) 1980-09-02
IE41928B1 (en) 1980-04-23
FI753127A (sv) 1976-05-08
YU281575A (en) 1983-01-21
SU673173A3 (ru) 1979-07-05
NO753713L (sv) 1976-05-10
NL177405B (nl) 1985-04-16
DD122684A5 (sv) 1976-10-20
SU604496A3 (ru) 1978-04-25
SE407063B (sv) 1979-03-12
BE835325A (fr) 1976-05-06
DE2550111C2 (de) 1983-09-15
FI60707B (fi) 1981-11-30
IE41928L (en) 1976-05-07
AR208800A1 (es) 1977-02-28
JPS5498790A (en) 1979-08-03
HU173108B (hu) 1979-02-28
CS231958B2 (en) 1985-01-16
YU39583B (en) 1985-03-20

Similar Documents

Publication Publication Date Title
DK141098C (sv)
FR2260957A1 (sv)
FR2264290A1 (sv)
FR2294344B3 (sv)
FR2262998B3 (sv)
JPS5127551U (sv)
FR2285221B1 (sv)
JPS5121588U (sv)
JPS50119385A (sv)
JPS50124132U (sv)
JPS50129879U (sv)
CH577591B5 (sv)
CH572126B5 (sv)
CH579503A5 (sv)
CH579330A5 (sv)
CH578792A5 (sv)
CH579883A5 (sv)
CH578457A5 (sv)
CH571754A5 (sv)
AU481917A (sv)
CH576631A5 (sv)
CH580091A5 (sv)
CH576175A5 (sv)
CH603251A5 (sv)
DD116081A1 (sv)